BMY
Bristol-Myers Squibb Co.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Market Cap: 108 Billion
Primary Exchange: NEW YORK STOCK EXCHANGE INC.
Website: https://www.bms.com/
Shares Outstanding: 2.02 Billion
Float: 0
Dividend: 2.274147016134742 (0.04%)
Beta: 0.4464566379043942
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 1713 trading days
From: 2016-07-14 To: 2022-04-06
Lowest Point:
Bristol-Myers Squibb Announces Dividend
via: Business Wire at 2019-06-13 12:38:00:000
The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of forty one cents ($0.41) per share on the $.10 par value Common Stock of the corporation. The next quarterly dividend will be payable on August 1, 2019, to stockholders of record at the … read more...
New Mechanistic Study Explores the Relationship Between a Key Genetic Marker and Clinical Efficacy of ORENCIA® (abatacept) or adalimumab in Moderate-to-Severe Early Rheumatoid Arthritis Patients
via: Business Wire at 2019-06-13 12:30:00:000
Findings from head-to-head Early AMPLE study are consistent with earlier studies, adding to body of research showing differences between mechanisms of biologic therapies Results suggest that a genetic marker linked to autoantibody production and a more severe RA disease course  … read more...
Akero Therapeutics Readies $75 Million IPO
via: SeekingAlpha at 2019-06-13 09:11:26:000
Quick Take Akero Therapeutics ( AKRO ) has filed to raise gross proceeds of $75.0 million from a U.S. IPO, according to an S-1/A registration statement . The firm is developing a treatment for metabolic diseases with high unmet clinical needs, with an initial focus on non-alcoholic steato… read more...
BIIB Is For Buy-O-Gen
via: SeekingAlpha at 2019-06-12 06:30:36:000
Let's spell Biogen Buy-o-Gen. Indeed, BIIB seems increasingly appealing at current price. The biotech focuses on discovering, developing, and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets various products for multiple sc… read more...
Iovance Makes Significant Impact At ASCO 2019 Conference With Cancer Drug
via: SeekingAlpha at 2019-06-11 10:52:56:000
Iovance Biotherapeutics ( IOVA ) had made a very large impact at ASCO 2019 and it was one of the clear winners for the medical conference. That's because it reported positive results from two of its studies. The positive results were made possible through the use of the biotech's Tumor infil… read more...
Week In Review: Frontage, A U.S.-China CRO, Stages $205 Million Hong Kong IPO
via: SeekingAlpha at 2019-06-10 00:47:20:000
Deals and Financings Frontage Holdings, a US-China CRO, raised $205 million in a Hong Kong IPO at a market capitalization of $820 million. It moved 4.5% higher on its first day of trading. According to Frontage, it will allocate 20% of the proceeds to meet increased demand, 40% for organic e… read more...
Chewy IPO, Lululemon And Tesla On Tap (Stocks To Watch Podcast)
via: SeekingAlpha at 2019-06-09 03:30:00:000
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks.. If you are interested in listening to Stocks To Watch to start your Sunday (you can r… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|---|---|---|---|---|---|---|---|
| 2019-10-03 | 2019-11-01 | 2019-10-04 | 2019-09-11 | 0.41 | No Change QoQ | |||
| 2019-07-03 | 2019-08-01 | 2019-07-05 | 2019-06-13 | 0.41 | No Change QoQ | |||
| 2019-04-04 | 2019-05-01 | 2019-04-05 | 2019-03-07 | 0.41 | No Change QoQ | |||
| 2019-01-03 | 2019-02-01 | 2019-01-04 | 2018-12-06 | 0.41 | Increase | |||
| 2018-10-04 | 2018-11-01 | 2018-10-05 | 2018-09-12 | 0.4 | No Change QoQ | |||
| 2018-07-05 | 2018-08-01 | 2018-07-06 | 2018-06-14 | 0.4 | No Change QoQ | |||
| 2018-04-05 | 2018-05-01 | 2018-04-06 | 2018-03-01 | 0.4 | No Change QoQ | |||
| 2018-01-04 | 2018-02-01 | 2018-01-05 | 2017-12-07 | 0.4 | Increase | |||
| 2017-10-05 | 2017-11-01 | 2017-10-06 | 2017-09-13 | 0.39 | No Change QoQ | |||
| 2017-07-05 | 2017-08-01 | 2017-07-07 | 2017-06-13 | 0.39 | No Change QoQ | |||
| 2017-04-05 | 2017-05-01 | 2017-04-07 | 2017-03-02 | 0.39 | No Change QoQ | |||
| 2017-01-04 | 2017-02-01 | 2017-01-06 | 2016-12-08 | 0.39 | Increase | |||
| 2016-10-05 | 2016-11-01 | 2016-10-07 | 2016-08-03 | 0.38 | No Change QoQ | |||
| 2016-06-29 | 2016-08-01 | 2016-07-01 | 2016-06-07 | 0.38 | No Change QoQ | |||
| 2016-03-30 | 2016-05-02 | 2016-04-01 | 2016-03-03 | 0.38 | No Change QoQ | |||
| 2015-12-30 | 2016-02-01 | 2016-01-04 | 2015-12-08 | 0.38 | Increase | |||
| 2015-09-30 | 2015-11-02 | 2015-10-02 | 2015-09-17 | 0.37 | No Change QoQ | |||
| 2015-07-01 | 2015-08-03 | 2015-07-06 | 2015-06-16 | 0.37 | No Change QoQ | |||
| 2015-04-01 | 2015-05-01 | 2015-04-06 | 2015-03-02 | 0.37 | No Change QoQ | |||
| 2014-12-30 | 2015-02-02 | 2015-01-02 | 2014-12-09 | 0.37 | Increase | |||
| 2014-10-01 | 2014-11-03 | 2014-10-03 | 2014-09-16 | 0.36 | No Change QoQ | |||
| 2019-10-03 | 2019-11-01 | 2019-10-04 | 2019-09-11 | 0.41 | Cash | |||
| 2020-01-02 | 2020-02-03 | 2020-01-03 | 2019-12-05 | 0.45 | Cash | |||
| 2020-04-02 | 2020-05-01 | 2020-04-03 | 2020-03-02 | 0.45 | Cash | |||
| 2020-07-02 | 2020-08-03 | 2020-07-06 | 2020-06-11 | 0.45 | Cash | |||
| 2020-10-01 | 2020-11-02 | 2020-10-02 | 2020-09-10 | 0.45 | Cash | |||
| 2020-12-31 | 2021-02-01 | 2021-01-04 | 2020-12-10 | 0.49 | Cash | |||
| 2021-03-31 | 2021-05-03 | 2021-04-01 | 2021-03-01 | 0.49 | Cash | |||
| 2021-07-01 | 2021-08-02 | 2021-07-02 | 2021-06-17 | 0.49 | Cash | |||
| 2021-09-30 | 2021-11-01 | 2021-10-01 | 2021-09-09 | 0.49 | Cash | |||
| 2022-01-06 | 2022-02-01 | 2022-01-07 | 2021-12-13 | 0.54 | Cash | |||
| 2022-03-31 | 2022-05-02 | 2022-04-01 | 2022-03-01 | 0.54 | Cash | |||
| 2022-06-30 | 2022-08-01 | 2022-07-01 | 2022-06-15 | 0.54 | Cash | |||
| 2022-10-06 | 2022-11-01 | 2022-10-07 | 2022-09-14 | 0.54 | Cash | |||
| 2023-01-05 | 2023-02-01 | 2023-01-06 | 2022-12-08 | 0.57 | Cash | |||
| 2023-04-06 | 2023-05-01 | 2023-04-10 | 2023-03-03 | 0.57 | Cash | |||
| 2023-07-06 | 2023-08-01 | 2023-07-07 | 2023-06-14 | 0.57 | Cash | |||
| 2023-10-05 | 2023-11-01 | 2023-10-06 | 2023-09-20 | 0.57 | Cash | |||
| 2024-01-04 | 2024-02-01 | 2024-01-05 | 2023-12-06 | 0.6 | Cash | |||
| 2024-04-04 | 2024-05-01 | 2024-04-05 | 2024-03-01 | 0.6 | Cash |
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|